An interventional study of Teach-back discharge education and Podcast discharge education in Cardiac Surgical Procedures, Coronary Artery Bypass and Heart Valve Diseases, sponsored by Suleyman Demirel University. Not yet recruiting at 1 site in Turkey (Türkiye). Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-12.
Sponsored by Suleyman Demirel University · Not applicable, Interventional, and Supportive care
Among 16 studies in Heart Valve Diseases with a site in Turkey — 5 open to participants now, 5 under way, none of them phase 3. Heart Valve Diseases · Turkey.
Among the 16 studies in Heart Valve Diseases with a site in Turkey, this one is one of 5 that started in 2026, is one of 7 with no phase, and was the 16th registered.
554 studies on the registry are indexed under Heart Valve Diseases; 164 are open to participants now.
Browse Heart Valve Diseases studies →5 of the 16 studies in Heart Valve Diseases with a site in Turkey are open now. Recruiting first, the newest first:
Saglik Bilimleri Universitesi Gazi Yasargil Training and Research Hospital · Sites in Turkey
Ages 18–75
Kartal Kosuyolu Yuksek Ihtisas Education and Research Hospital · Sites in Turkey, Italy
Ages 18+
Centre Chirurgical Marie Lannelongue · Sites in Turkey, Belgium, Czechia and 9 more countries
Ages 16–110
Osman Sila Aydin · Sites in Turkey
Ages 18+
A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →
Of the 118 Heart Valve Diseases studies recruiting now, 93 (79%) set no upper age limit and 10 (8%) stop at 75 or younger; 16 take children under 18; 15 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
16 studies; the count open now beside each. This study's row is marked.
First in 2008; this study’s year is marked. 5 started in 2026.
This study's planned enrollment of 90 is close to the median of 100 across 313 interventional studies indexed under Heart Valve Diseases.
Median enrollment 78 across the 8 interventional studies, 142 across the 8 observational. Of the 8 that completed or were terminated, 1 (13%) have results posted.
This tab as a report to print or save as PDF → With an account.
1 of 16 have an industry lead sponsor. The 10 most frequent:
Suleyman Demirel University is the lead sponsor of 128 studies on the registry; 36 are open to participants now.
Suleyman Demirel University has 1 study filed under Heart Valve Diseases — fewer than ten, so there is no comparison to draw.
2 of the studies in Heart Valve Diseases with a site in Turkey that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07588230Saglik Bilimleri Universitesi Gazi Yasargil Training and Research HospitalSerratus Posterior Superior Intercostal Plane Block in Minimally Invasive Cardiac Surgery | 2026-12-25 |
| NCT07858578Osman Sila AydinTranscranial Doppler and Artificial Intelligence Prediction of Postoperative Delirium in Heart Valve Surgery | 2027-08-01 |
Add all 2 to your calendar (.ics) → With an account.
Among the 16 studies in Heart Valve Diseases with a site in Turkey, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The aim of this study is to determine the effect of discharge education delivered by the teach-back method and by podcast on discharge readiness, self-efficacy, and postoperative recovery in patients undergoing open heart surgery. Ninety patients will be randomly assigned to a teach-back group, a podcast group, or a control group receiving routine care. Discharge readiness and self-efficacy will be measured on the day of discharge, and self-efficacy and postoperative recovery will be measured one month after discharge.
This three-arm, parallel-group randomized controlled trial (1:1:1) will enroll 90 adults undergoing first-time elective open heart surgery at University hospital in Turkey. The education content, covering wound care, pain, medications, daily activities, nutrition, psychological status, warning signs, and mechanical valve care, was reviewed by 5 experts. On the day before discharge, the teach-back group will receive education with the teach-back method, and the podcast group will listen to an audio recording of the same content. The control group will receive routine care. All patients will receive the clinic's standard brochure after discharge-day measurements. Randomization uses permuted blocks of varying sizes with sealed opaque envelopes, and outcomes will be assessed by a researcher on the day of discharge (face to face) and one month after discharge (by telephone).
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Discharge education delivered using the prepared education content on the day before discharge. Patients explain the information in their own words; missing or incorrect information is repeated until the patient demonstrates understanding. The clinic's standard discharge brochure is given at discharge.
Behavioral: Teach-back discharge education
The same education content recorded as audio and played to patients on the day before discharge. The clinic's standard discharge brochure is given at discharge.
Behavioral: Podcast discharge education
Routine care and routine discharge education of the clinic, including the clinic's standard discharge brochure given at discharge. No additional intervention.
Discharge education is given individually by the researcher on the day before discharge using the prepared education content (wound care, pain management, medication use, activities of daily living, compression stockings and sternal support vest, nutrition, psychological status, warning signs, and mechanical valve care). After the session, the patient explains the information in their own words; missing or incorrect information is re-taught until the patient demonstrates understanding.
Also known as: Teach-back method
The same education content is recorded as audio and played to the patient on the day before discharge. The audio material was evaluated by 5 experts using the Patient Education Materials Assessment Tool for Audiovisual Materials (PEMAT-A/V).
Also known as: Audio-recorded discharge education
Self-efficacy at discharge
Barnason Efficacy Expectation Scale-Cardiac Surgery Version (15 items, 4-point Likert; total score 15-60). Higher scores indicate higher self-efficacy expectation.
Time frame: From surgery to hospital discharge, an average of 7 days
Discharge readiness
Readiness for Hospital Discharge Scale-Short Form (8 items, 0-10; mean score). Higher scores indicate greater readiness for discharge.
Time frame: From surgery to hospital discharge, an average of 7 days
Self-efficacy at one month
Barnason Efficacy Expectation Scale-Cardiac Surgery Version, administered by telephone. Higher scores indicate higher self-efficacy expectation.
Time frame: From hospital discharge to 1 month after discharge
Postoperative recovery
Postoperative Recovery Index, Turkish version (25 items, 5 subscales; mean score). Higher scores indicate greater difficulty in recovery.
Time frame: From hospital discharge to 1 month after discharge
Hospital readmissions and emergency visits
Number of hospital readmissions and emergency department visits after discharge, self-reported by telephone.
Time frame: From hospital discharge to 1 month after discharge
Plan to share: No — Individual participant data will not be shared publicly; data are available from the corresponding author upon reasonable request.
Start is estimated for Nov 2026; primary completion for Dec 2027, 13 months later.
Of 108 non-industry interventional studies with no phase under Heart Valve Diseases, half reached primary completion within 28 months of starting (the median), counting those still running; a quarter within 16 and three quarters within 53. This study's planned 13 months is below that.
Counting every sponsor, half of 153 studies reached it within 30 months; a quarter within 16 and three quarters within 55.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is not yet recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.